asthma
highli
preval
chronic
respiratori
condit
character
revers
airflow
obstruct
airway
hyperrespons
airway
inflamm
produc
frequent
exacerb
million
peopl
worldwid
affect
public
health
burden
asthma
increas
past
decad
acut
exacerb
asthma
particularli
import
costli
problem
morbid
mortal
due
asthma
close
relat
frequenc
sever
identif
causal
factor
vital
prevent
manag
exacerb
western
countri
viral
infect
respons
exacerb
childhood
contrast
viral
infect
involv
asthma
exacerb
among
adult
among
variou
respiratori
tract
virus
includ
rhinoviru
rv
influenza
viru
ifv
adenoviru
adv
human
metapneumoviru
hmpv
parainfluenza
viru
piv
coronaviru
respiratori
syncyti
viru
rsv
rv
ifv
trigger
exacerb
children
asthma
korea
preval
respiratori
virus
report
similar
western
countri
respiratori
virus
caus
asthma
exacerb
rv
ifv
rsv
respons
substanti
proport
exacerb
children
howev
report
preval
virus
relat
asthma
exacerb
korean
adult
asthmat
prompt
us
evalu
preval
respiratori
virus
sputum
asthmat
lower
respiratori
tract
ill
lrti
compar
frequenc
type
virus
detect
patient
exacerb
exacerb
lrti
subject
without
exacerb
stabl
lrti
evalu
contribut
respiratori
virus
asthma
exacerb
studi
prospect
carri
tertiari
hospit
korea
june
june
asthma
previous
diagnos
base
global
initi
asthma
guidelin
gina
report
global
strategi
asthma
manag
prevent
may
avail
http
subject
clinic
diagnosi
asthma
support
least
one
follow
criteria
increas
forc
expiratori
volum
second
ml
inhal
albuterol
reduct
respons
provoc
concentr
mgml
inhal
methacholin
increas
day
inhal
system
corticosteroid
use
subject
underw
standard
assess
includ
analys
induc
sputum
specimen
complet
blood
cell
count
differenti
count
total
immunoglobulin
e
ige
measur
chest
radiographi
bodi
mass
index
bmi
measur
allergi
skinprick
test
initi
visit
twentyfour
common
inhal
allergen
includ
dust
mite
dermatophagoid
farina
dermatophagoid
pteronyssinu
cat
fur
dog
fur
cockroach
grass
pollen
tree
pollen
ragwe
pollen
aspergillu
speci
bencard
co
brentford
uk
use
skinprick
test
studi
prospect
perform
includ
patient
soonchunhyang
asthma
cohort
characterist
summar
previou
among
recruit
complain
aggrav
lower
respiratori
symptom
abl
expector
good
qualiti
sputum
sampl
exclus
criteria
presenc
parenchym
lung
diseas
pulmonari
tuberculosi
bronchiectasi
lung
cancer
idiopath
interstiti
lung
diseas
abnorm
lung
infiltr
chest
radiographi
sputum
obtain
within
week
time
respiratori
tract
infect
suspect
common
symptom
upper
respiratori
tract
ill
urti
cough
sore
throat
runni
nose
postnas
drip
nasal
congest
lowgrad
fever
lrti
short
breath
weak
fever
cough
sputum
product
wheez
present
exacerb
diagnos
preexist
dyspnea
wheez
becam
aggrav
within
day
studi
togeth
postbronchodil
person
divid
exacerb
lrti
stabl
lrti
inform
written
consent
obtain
subject
procedur
approv
ethic
committe
soonchunhyang
univers
bucheon
hospit
sputum
induc
use
isoton
salin
contain
shortact
bronchodil
sampl
process
within
hour
collect
previous
briefli
portion
visibl
greater
solid
care
select
place
preweigh
eppendorf
tube
sampl
dilut
ad
volum
dulbecco
phosphatebuff
salin
total
cell
count
determin
use
hemocytomet
supernat
cell
fraction
separ
centrifug
minut
five
hundr
cell
differenti
count
slide
produc
cytocentrifug
stain
diffquick
american
scientif
product
mcgraw
park
il
usa
sputum
sampl
contain
squamou
epitheli
cell
includ
viral
rna
extract
total
sputum
sampl
dilut
phosphatebuff
salin
dpb
use
viral
kit
intron
biotechnolog
seoul
korea
recommend
manufactur
isol
rna
reversetranscrib
cdna
follow
protocol
revertaid
first
strand
cdna
synthesi
kit
thermoscientif
waltham
usa
purifi
rna
random
hexam
primer
diethylpyrocarbon
depc
treat
water
mix
heat
minut
mixtur
buffer
ribolock
rnase
inhibitor
mm
dntp
mix
revertaid
mmulvrt
ad
follow
incub
minut
minut
respiratori
virus
identifi
use
rv
detect
kit
seegen
seoul
korea
accord
manufactur
protocol
follow
cdna
primer
solut
master
mix
mix
heat
minut
forti
amplif
cycl
carri
thermal
cycler
minut
minut
minut
amplif
complet
final
extens
step
minut
rtpcr
product
visual
electrophoresi
ethidium
bromidestain
agaros
gel
identifi
adv
hmpv
piv
ifv
ifv
b
rsv
ab
rv
statist
analys
perform
use
spss
ibm
armonk
ny
usa
comparison
clinic
physiolog
paramet
exacerb
stabl
group
conduct
use
pearson
test
independ
test
discret
continu
variabl
respect
fisher
exact
test
appli
comparison
detect
frequenc
exacerb
stabl
group
data
express
error
se
mean
valu
p
deem
indic
statist
signific
obtain
sputum
sampl
asthmat
urti
lrti
symptom
includ
increas
amount
sputum
without
asthma
exacerb
stabl
state
asthma
exacerb
exacerb
state
among
sputum
sampl
discard
inadequ
qualiti
pcr
detect
respiratori
virus
perform
sampl
asthmat
sampl
subject
exacerb
state
stabl
state
clinic
profil
subject
state
present
tabl
exacerb
case
significantli
lower
forc
vital
capac
fvc
valu
compar
stabl
state
p
total
ige
level
eosinophil
percentag
peripher
blood
sputum
significantli
higher
exacerb
case
stabl
case
respiratori
virus
detect
exacerbatedst
sputum
sampl
stablest
sampl
fig
rv
frequent
detect
viru
exacerb
stabl
case
vs
tabl
exacerb
case
ifv
ab
second
frequent
detect
viru
follow
piv
rsv
ab
adv
hmpv
stabl
case
rsv
ab
second
frequent
detect
follow
piv
ifv
ab
tabl
fig
differ
viru
distribut
exacerb
stabl
group
fig
subject
stabl
exacerb
case
underw
one
sputum
examin
remain
underw
sputum
examin
seventi
sampl
obtain
subject
exacerb
exacerbatedexacerb
sampl
obtain
subject
exacerb
stabl
lrti
state
exacerbatedst
tabl
viru
detect
examin
exacerbatedexacerb
case
one
examin
case
case
neither
examin
case
among
exacerbatedst
case
viru
detect
one
examin
case
case
first
examin
case
second
examin
detect
case
signific
differ
virusposit
neg
rate
group
interestingli
among
exacerbatedst
case
virusposit
initi
sputum
sampl
exacerb
state
virusneg
second
sputum
sampl
stabl
state
accordingli
exacerbatedst
group
significantli
higher
frequenc
initi
posit
sampl
followup
neg
sampl
exacerbatedexacerb
group
tabl
season
pattern
note
rate
detect
respiratori
viru
rv
preval
septemb
decemb
ifv
januari
april
piv
may
septemb
rsv
ab
septemb
april
fig
present
studi
virus
evalu
rv
frequent
relat
exacerb
asthma
korean
adult
asthmat
rv
respons
onethird
viral
infect
exacerb
case
frequenc
good
agreement
previou
report
caucasian
rv
urti
lrti
frequent
associ
asthma
exacerb
child
adult
caucasian
nicholson
et
report
acut
exacerb
case
rvposit
rtpcr
longitudin
studi
adult
patient
report
rv
detect
rate
studi
adult
asthmat
hospit
due
respiratori
viral
infect
rv
detect
subject
thu
rv
constitut
respiratori
virus
relat
asthma
exacerb
korean
caucasian
adult
asthmat
preval
respiratori
virus
differ
markedli
accord
age
frequenc
rv
detect
significantli
lower
adult
asthmat
child
asthmat
inde
virus
detect
child
asthmat
acut
exacerb
rv
caus
interestingli
frequenc
rv
detect
higher
nonexacerb
stabl
lrti
case
exacerb
lrti
case
studi
vs
although
differ
signific
thu
rv
detect
almost
half
stabl
lrti
case
relationship
rv
infect
asthma
exacerb
seem
inconsist
detect
rv
sputum
alway
induc
asthma
exacerb
studi
adult
asthmat
report
similar
result
month
longitudin
studi
atop
asthmat
age
year
virus
detect
associ
asthma
popul
rv
detect
asthmat
nonasthmat
longitudin
studi
adult
asthmat
report
onethird
symptomat
respiratori
tract
viral
infect
associ
worsen
asthma
recent
longitudin
cohort
studi
coupl
asthma
without
evalu
presenc
rv
nasal
secret
interv
period
incid
rv
infect
similar
asthma
without
vs
studi
children
rate
rv
isol
almost
ident
wheezi
bronchiti
upper
respiratori
ill
studi
data
suggest
rv
relat
acut
exacerb
asthma
stabl
lrti
without
asthma
exacerb
although
preval
viru
infect
similar
asthmat
children
vs
without
exacerb
respiratori
symptom
sever
presenc
viral
infect
cold
asthma
symptom
longer
durat
loss
control
frequent
virusposit
compar
virusneg
respiratori
tract
ill
children
vs
adult
asthma
increas
risk
rv
infect
infect
rv
sever
longerlast
lrti
symptom
greater
decreas
peak
expiratori
flow
rate
healthi
present
studi
ifv
second
frequent
detect
viru
thu
rv
ifv
constitut
viral
infect
subject
exacerb
asthma
similar
frequenc
report
adult
howev
rv
ifv
infect
preval
among
subject
asthma
exacerb
compar
without
exacerb
korean
present
studi
respiratori
virus
detect
sputum
subject
exacerb
stabl
asthma
detect
rate
lower
initi
expect
studi
children
detect
rate
studi
viru
isol
perform
cell
contrast
respiratori
virus
identifi
viru
cultur
serolog
immunofluoresc
antigen
detect
pcrbase
sinc
develop
pcr
assay
sensit
improv
markedli
thu
detect
rate
rel
low
like
due
inadequ
sputum
sampl
viru
detect
usual
perform
upper
airway
collect
sputum
young
children
adult
asthmat
feasibl
studi
virus
detect
sputum
sampl
nasopharyng
wash
swab
use
method
may
result
low
frequenc
rv
detect
studi
rv
usual
infect
upper
respiratori
howev
comparison
studi
sputum
nasal
swab
asthmat
concord
rate
viru
detect
detect
rate
higher
sputum
nasal
swab
thu
use
sputum
seem
caus
low
frequenc
rv
detect
studi
second
reason
delay
sampl
sputum
studi
exacerb
defin
aggrav
preexist
symptom
dyspnea
wheez
within
day
studi
postbronchodil
predict
valu
person
rv
incub
period
day
shed
day
develop
decreas
significantli
infect
reach
minimum
day
experiment
rv
studi
crosssect
design
analyz
lag
time
appear
lrti
symptom
sputum
viru
analysi
therefor
lag
time
day
patient
may
result
low
detect
rate
subset
asthmat
particularli
suscept
recurr
studi
initi
sputum
sampl
exacerb
posit
viru
second
sputum
sampl
stabl
state
neg
case
frequenc
higher
exacerbatedexacerb
group
data
indic
subset
patient
suscept
asthma
exacerb
presenc
viral
lrti
addit
virus
asthma
exacerb
caus
agent
includ
allergen
dust
mite
pollen
anim
dander
occup
exposur
grain
flour
clean
agent
metal
irrit
wood
hormon
menstrual
asthma
drug
acetylsalicyl
acid
asa
nonsteroid
antiinflammatori
drug
nsaid
betablock
exercis
stress
smoke
air
factor
trigger
exacerb
differ
among
individu
thu
exacerb
asthma
may
result
complex
interplay
among
respiratori
virus
host
airway
suscept
factor
environment
modifi
casecontrol
studi
adult
patient
compar
hospit
acut
asthma
control
group
patient
stabl
asthma
patient
hospit
nonasthma
compar
control
significantli
higher
proport
acut
asthmat
sensit
expos
allergen
includ
dust
mite
cat
dog
allergen
intriguingli
combin
high
exposur
allergen
viru
detect
significantli
increas
risk
hospit
asthma
compar
control
stabl
result
indic
synerg
among
allergen
sensit
exposur
high
level
sensit
allergen
viral
infect
induc
asthma
studi
frequenc
viru
detect
differ
atop
nonatop
data
shown
although
factor
expect
predispos
asthmat
viral
determin
whether
exacerb
due
viral
infect
caus
feasibl
present
predomin
respiratori
viru
depend
studi
number
case
highest
late
fall
earli
winter
howev
viru
detect
rate
februari
march
may
juli
august
data
indic
symptom
lrti
asthma
exacerb
earli
spring
may
due
mainli
viral
infect
late
spring
summer
may
due
mainli
environment
factor
addit
viru
preval
vari
markedli
rv
predomin
fall
earli
winter
ifv
predomin
winter
ifv
predomin
respiratori
viru
winter
rsv
predomin
fall
winter
earli
spring
piv
predomin
late
spring
earli
fall
season
variat
report
present
studi
agreement
previous
summari
presenc
respiratori
virus
analyz
sputum
sampl
asthmat
manifest
lrti
evalu
contribut
asthma
exacerb
viru
detect
approxim
onefifth
subject
exacerb
stabl
diseas
state
rv
frequent
detect
viru
follow
ifv
compar
caucasian
studi
fortynin
patient
underw
examin
virus
episod
exacerb
time
exacerb
stabl
episod
viru
detect
rate
second
examin
significantli
higher
case
exacerb
episod
sequenti
exacerb
stabl
episod
suggest
presenc
suscept
asthmat
exacerb
case
ltri
season
variat
detect
rate
type
viru
show
similar
pattern
caucasian
asthmat
